Genflow Biosciences plc (GENFF)

Market Cap	4.74M
Revenue (ttm)	n/a
Net Income (ttm)	-1.99M
Shares Out	n/a
EPS (ttm)	-0.01
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	10,030
Average Volume	2,173
Open	0.0115
Previous Close	0.0115
Day's Range	0.0115 - 0.0115
52-Week Range	0.0101 - 0.0605
Beta	2.21
RSI	38.05
Earnings Date	Jun 27, 2025

About Genflow Biosciences

Genflow Biosciences plc, together with its subsidiaries, operates as a biotechnology company that focuses on developing biological interventions aimed at tackling the effects of ageing, slowing, and halting the ageing process, and reducing the incidence of age-related diseases with increase in health span in the United Kingdom and Belgium. Its lead compound is GF-1002, a suspension of an adeno-associated viral vector-based gene therapy for intravenous infusion. The company is also developing GF-3001, a topical delivery of SIRT6 to the skin; and...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2021
• Employees: 5
• Stock Exchange: OTCMKTS
• Ticker Symbol: GENFF

Financial Performance

Financial numbers in GBP